TY - JOUR
T1 - Screening for lungecancer med lavdosis-CT kræver grundige overvejelser
AU - Saghir, Zaigham
AU - Dirksen, Asger
AU - Ashraf, Haseem
AU - Bach, Karen Skjøldstrup
AU - Brodersen, John
AU - Clementsen, Paul Frost
AU - Døssing, Martin
AU - Hansen, Hanne
AU - Kofoed, Klaus Fuglsang
AU - Larsen, Klaus Richter
AU - Mortensen, Jann
AU - Rasmussen, Jakob Fraes
AU - Thomsen, Laura Hohwü
AU - Wille, Mathilde Marie Winkler
AU - Seersholm, Niels
AU - Skov, Birgit Guldhammer
AU - Thorsen, Hanne
AU - Tønnesen, Philip
AU - Pedersen, Jesper Holst
PY - 2015
Y1 - 2015
N2 - Results from the American National Lung Screening Trial (NLST) show a significant reduction in lung cancer and all-cause mortality in a high risk population screened with annual low-dose CT. Handling of pulmonary nodules, false positive tests, overdiagnosis, psychosocial consequences and cost-efficiency etc. are all aspects that require careful consideration. This paper gives an overview of the current knowledge on these issues. Before a recommendation can be made, we need an overall evaluation of both the benefits and harms in CT screening for lung cancer.
AB - Results from the American National Lung Screening Trial (NLST) show a significant reduction in lung cancer and all-cause mortality in a high risk population screened with annual low-dose CT. Handling of pulmonary nodules, false positive tests, overdiagnosis, psychosocial consequences and cost-efficiency etc. are all aspects that require careful consideration. This paper gives an overview of the current knowledge on these issues. Before a recommendation can be made, we need an overall evaluation of both the benefits and harms in CT screening for lung cancer.
M3 - Review
C2 - 25316363
SN - 1603-6824
VL - 177
SP - 436
EP - 439
JO - Ugeskrift for læger [online]
JF - Ugeskrift for læger [online]
IS - 5
M1 - V06140341
ER -